GLP-1 agonists (Byetta, etc) are a good choice for weight loss in patients WITHOUT diabetes.
January 1
This isn’t completely true. GLP-1 agonists do result in short-term weight loss, but safety is a concern.
Alternative weight loss meds are tempting in light of all the cardiovascular and other concerns with antiobesity drugs.
GLP-1 agonists seem to cause weight loss by slowing gastric motility, increasing satiety, and suppressing appetite.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote